Lantibiotics: mode of action, biosynthesis and bioengineering.
about
Evolution of lanthipeptide synthetasesLanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionProtein Defense Systems against the Lantibiotic Nisin: Function of the Immunity Protein NisI and the Resistance Protein NSRNovel formulations for antimicrobial peptidesAntimicrobial peptides in 2014Antibiotic alternatives: the substitution of antibiotics in animal husbandry?The First Structure of a Lantibiotic Immunity Protein, SpaI from Bacillus subtilis, Reveals a Novel FoldLantibiotic resistance.Distinct mechanisms contribute to immunity in the lantibiotic NAI-107 producer strain Microbispora ATCC PTA-5024Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of BacteriaBioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogensA bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermediusIn Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus BiofilmsAntimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria.The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.[Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia].Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13BAGEL2: mining for bacteriocins in genomic data.Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Human antimicrobial peptides and proteinsIn silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria.Identification and analysis of the biosynthetic gene cluster encoding the thiopeptide antibiotic cyclothiazomycin in Streptomyces hygroscopicus 10-22.Staphylococcus colonization of the skin and antimicrobial peptides.Bacterial display and screening of posttranslationally thioether-stabilized peptides.Host-guest chemistry of the peptidoglycanSuicin 90-1330 from a nonvirulent strain of Streptococcus suis: a nisin-related lantibiotic active on gram-positive swine pathogens.Protein tyrosine O-glycosylation--a rather unexplored prokaryotic glycosylation system.ApnI, a transmembrane protein responsible for subtilomycin immunity, unveils a novel model for lantibiotic immunity.Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.Lipid-II forms potential "landing terrain" for lantibiotics in simulated bacterial membrane.Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilisD-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall densityThe evolving role of chemical synthesis in antibacterial drug discovery.Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli.When the leader gets loose: in vivo biosynthesis of a leaderless prenisin is stimulated by a trans-acting leader peptide.Autoregulation of lantibiotic bovicin HJ50 biosynthesis by the BovK-BovR two-component signal transduction system in Streptococcus bovis HJ50.In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.High divergence of the precursor peptides in combinatorial lanthipeptide biosynthesis.
P2860
Q24615015-4F57D802-7A39-4872-87F4-5D850ED691ADQ26748638-0C109832-A72B-4F9C-9D4C-5A16CB28A980Q26752597-AD98D177-308A-40FC-AB23-EC86A9F7FC84Q26991771-4F416CBC-7B77-4151-A7EF-70F657682673Q27027316-5BC8F1C4-29D1-4A86-896B-EBBA5CED081FQ27027984-B9B2A5DF-4FE1-4EB1-BB5B-B8FF868C1152Q27671593-362294F9-E164-4E3E-9C74-077F03965473Q27692563-23498033-1839-4288-9B13-68E999D469C0Q27700284-B482CA95-91DF-4FB2-89A2-220A0EC3B580Q28072687-248C0210-8021-4D92-8BF0-784B0EEACB42Q28484253-B5695343-EEFF-4E24-B23B-CF85FE91FC31Q28544703-ECEBCD72-4B48-4A33-B8CC-D96F50E02910Q28834620-FE6125EC-9495-4554-AEBF-46F57CE2C94BQ30399098-3C9E0C66-A56C-4BFC-AEFC-8A10597573F8Q31027644-CD96B837-D070-4FF0-BC47-B13FFFA75A7FQ31140261-384F25CC-2AC5-4E6A-810B-DCD47E352D47Q33415155-764F0F81-A50B-436F-880B-985B4CC5AD21Q33496732-C0254EA6-7340-4BFA-9D60-36310EE3DC17Q33576481-4800BCE6-EB49-4080-937E-A1DC3B724783Q33664443-E2020DD7-5942-4C32-A4D8-9AF8D0CE52E5Q33673156-7396CD32-9FCA-4516-9E84-2774D4C74B82Q33759122-07756EC4-888B-4D2C-B421-2D5FBE9F81DAQ33768281-F69A5EEA-7BBD-4777-B742-7C16C92D71DAQ33840268-4E5DEFB0-DEA1-4160-B4BF-18989482C607Q33984610-FC3D5F79-D45E-478E-BC65-C07E180EC249Q34013593-8A9DF869-34B0-416F-9BCC-A02BE340C6C1Q34058400-0F3FA760-3043-40F8-AA6A-A00EDF1E143AQ34101869-CDC37F45-6E88-4452-8C00-ED18D5FCB08BQ34261125-47E3F8C1-75A1-4CAE-88B5-5297EB23144DQ34312732-60254A89-0B8A-47C4-9E6D-B6AFEE064D87Q34339406-BBE511D8-A69D-4FDE-A52F-022544458B04Q34394918-064A25BA-97B5-4DF0-A486-F044D3C5C223Q34410541-902D637A-32EB-4B86-BC5C-51BB902726C2Q34411837-F70CED34-0E1A-4FDA-A6FB-653FC9CA3D62Q34427652-0201F239-0613-4120-A679-5363A8ACBA03Q34433222-16589F45-EB3D-4242-825E-F5DD1A52CE8AQ34446536-A4302B2C-4E52-44C1-86E8-1D31067E0E6FQ34487954-0D37D30A-4B1E-42C1-94C3-56D5EF40F64EQ34572089-EA6B3E8C-E401-43E6-8003-6F0B548D8A7FQ34576266-2BAE648D-19A1-456D-8E07-1EC16D3E41D6
P2860
Lantibiotics: mode of action, biosynthesis and bioengineering.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Lantibiotics: mode of action, biosynthesis and bioengineering.
@en
Lantibiotics: mode of action, biosynthesis and bioengineering.
@nl
type
label
Lantibiotics: mode of action, biosynthesis and bioengineering.
@en
Lantibiotics: mode of action, biosynthesis and bioengineering.
@nl
prefLabel
Lantibiotics: mode of action, biosynthesis and bioengineering.
@en
Lantibiotics: mode of action, biosynthesis and bioengineering.
@nl
P1476
Lantibiotics: mode of action, biosynthesis and bioengineering.
@en
P2093
P356
10.2174/138920109787048616
P577
2009-01-01T00:00:00Z